Our shareholders fully support our vision to make the world’s best and most sustainable biomaterials accessible to everyone. Together, we have the goal of making AMSilk a global leader in bioengineered performance materials. In 2008, AMSilk was founded as spin-off from the Technical University of Munich. Thanks to the support of the shareholders AT Newtec GmbH and MIG Fonds, we were able to grow from a humble startup into a well-established, reputable industry partner in the field of biomaterial products. We are grateful that our initial shareholders have supported us since the very beginning of our journey. In 2021, additional and renowned shareholders joined the Company, supporting us to make the next step.
Together with our existing shareholders and with Novo Holdings, Cargill and E.R. Capital Holding, we can accelerate industrialization and expand commercial operations into new markets.